[PRESS RELEASE – San Diego, United States, November 17th, 2025]
LITS Is the First and Solely US Publicly Traded Firm to Achieve Institutional Publicity to LTC, Holding 929,548 LTC Tokens.
Lite Technique, Inc. (NASDAQ: LITS) (“Lite Technique” or “LITS”) at this time reported outcomes for its first quarter ended September 30, 2025, and highlighted current company occasions associated to the Firm’s digital asset treasury technique in addition to its pharmaceutical operations.
“Our first quarter was extremely profitable for LITS. We launched our digital treasury technique, positioning ourselves because the main public holder of LTC, and up to date our company profile to bolster our new focus,” Board Member Charlie Lee stated. “We just lately celebrated Litecoin’s 14th anniversary and its unblemished monitor file of reliability and uptime. LITS gives traders the one US publicly traded firm to achieve institutional publicity to Litecoin, each for portfolio diversification and long-term worth.”
“Fiscal yr 2026 will showcase the outcomes of the transformative steps taken by Lite Technique. For the reason that begin of our strategic alternate options course of in fiscal yr 2025, now we have prioritized maximizing the worth of our belongings for stockholders. Beginning with the profitable sale of our scientific asset, ME-344 (now often known as WE-868), presently being developed for adults with weight problems at Aardvark Therapeutics, and persevering with by way of the shut of our $100 million PIPE providing in July 2025 that kicked off our Litecoin digital asset treasury technique within the first quarter of this fiscal yr,” stated Jay File, CEO, CFO.
First Quarter Fiscal 12 months 2026 and Current Highlights
- Raised $100 million in combination gross proceeds, commencing the Firm’s long-term strategic plan with Litecoin as a digital asset treasury reserve asset.
- Formally grew to become the primary U.S.-listed public firm to undertake Litecoin as a major reserve asset with the acquisition of 929,548 Litecoin (LTC) tokens, implementing a brand new technique constructed on a digital asset infrastructure and long-term capital innovation.
- Entered right into a strategic partnership with GSR, a number one crypto funding agency, to information LITS’ digital asset treasury technique, guaranteeing strong governance, execution, and market experience.
- Introduced on world-class board members, Charlie Lee, creator of Litecoin, and Joshua Riezman, U.S. Chief Technique Officer at GSR.
- Rebranded from MEI Pharma to Lite Technique, together with altering the Firm’s company identify and NASDAQ Inventory Market ticker from MEIP to LITS, and unveiling a brand new company brand and web site. The rebranding underscores the Firm’s dedication to constructing a long-term company technique round LTC as its major reserve asset.
- In October introduced a $25 million share repurchase program, advancing LITS from the preliminary section of Litecoin accumulation to lively capital market operations and permitting LITS to leverage our almost 1 million LTC treasury – a key differential from passive funding buildings like exchange-traded funds.
“As we progress additional into fiscal yr 2026, we proceed to judge our scientific belongings together with the graduation of pre-clinical research with voruciclib in non-oncology illness indications for potential licensing to 3rd events, and pursuing licensing or sale alternatives with zandelisib,” stated Jay File. “We’ll take into account alternatives to deploy our just lately introduced $25 million inventory buyback program till our low cost to NAV is normalized. We look ahead to executing on all our company aims as we progress by way of fiscal yr 2026.”
As of September 30, 2025, the Firm had $12.21 million in working capital with no excellent debt.
To be taught extra about Lite Technique, go to the Firm’s homepage at https://litestrategy.com.
To be taught extra about Litecoin and its function in Lite Technique’s treasury, go to the About Litecoin web page at https://litestrategy.com/about-litecoin/.
To be taught extra in regards to the transaction with Aardvark, learn the Type 8-Ok submitting at https://investor.meipharma.com/sec-filings/sec-filing/8-k/0000950170-24-117406.
For present holdings and associated Firm metrics, go to Lite Technique’s dashboard at https://litestrategy.com/dashboard/.
About Lite Technique, Inc. (LITS)
Lite Technique, Inc. (NASDAQ: LITS) is the primary U.S. publicly traded firm to undertake Litecoin as its major reserve asset. Previously MEI Pharma, the Firm has expanded its enterprise mannequin past its portfolio of drug candidates to concentrate on pioneering institutional-grade digital asset treasury methods, in partnership with main innovators throughout blockchain, finance, and expertise.
Ahead-Wanting Statements
Sure data contained on this press launch that aren’t historic in nature are “forward-looking statements” throughout the which means of the “secure harbor” provisions of the Personal Securities Litigation Reform Act of 1995 together with, with out limitation, statements concerning our future actions, potential merchandise and actions, future efficiency or outcomes. You have to be conscious that our precise outcomes might differ materially from these contained within the forward-looking statements, that are primarily based on administration’s present expectations and are topic to plenty of dangers and uncertainties, together with, however not restricted to, threat referring to with the ability to repurchase our shares available in the market on engaging phrases or in any respect, sustaining our present itemizing on Nasdaq, our capability to retain and entice senior administration and different key staff, fluctuations available in the market value of LTC and any related impairment expenses that we could incur because of a lower available in the market value of LTC beneath the worth at which LTC is carried on our steadiness sheet, adjustments within the accounting remedy referring to our LTC holdings, our capability to realize worthwhile operations, authorities regulation of cryptocurrencies and on-line betting, adjustments in securities legal guidelines or laws, buyer acceptance of latest services and products together with our LTC treasury technique, our capability to make the most of our repurchase program, the demand for our merchandise and our clients’ financial situation, the impression of aggressive merchandise and pricing, our proprietary rights, normal financial circumstances and different threat components detailed in our annual report and different filings with the SEC. We don’t intend to replace any of those components or to publicly announce the outcomes of any revisions to those forward-looking statements.
The put up Lite Technique Stories First Quarter Fiscal 12 months 2026 Outcomes: Highlights Profitable Launch of $100M Litecoin Treasury Technique and Motion into Lively Capital Market Operations appeared first on CryptoPotato.